MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

05 May 2022 Evaluate
The March 2022 quarter revenue stood at Rs. 2678.20 millions, up 22.21% as compared to Rs. 2191.50 millions during the corresponding quarter last year.The Net Profit of the company vaulted to 224.41% to Rs. 511.60  millions from Rs. 157.70 millions in the previous quarter.Operating profit surged to 711.20 millions from the corresponding previous quarter of 339.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202106 202006 % Var
Sales 2678.20 2191.50 22.21 8185.20 7233.40 13.16 10087.30 8911.96 13.19
Other Income 23.50 32.40 -27.47 100.90 156.80 -35.65 181.00 337.27 -46.33
PBIDT 711.20 339.70 109.36 2187.70 2132.60 2.58 2641.20 2444.80 8.03
Interest 1.40 2.00 -30.00 4.00 6.30 -36.51 8.00 0.00 0.00
PBDT 709.80 337.70 110.19 2183.70 2126.30 2.70 2633.20 2444.80 7.71
Depreciation 61.20 76.70 -20.21 196.10 228.80 -14.29 300.40 206.18 45.70
PBT 648.60 261.00 148.51 1987.60 1897.50 4.75 2332.80 2238.62 4.21
TAX 137.00 103.30 32.62 473.90 468.40 1.17 564.80 545.70 3.50
Deferred Tax -5.90 2.80 -310.71 -10.90 -11.30 -3.54 -49.00 94.90 -151.63
PAT 511.60 157.70 224.41 1513.70 1429.10 5.92 1768.00 1692.92 4.43
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 26.56 15.50 71.32 26.73 29.48 -9.35 26.18 27.43 -4.55
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..